Due to the pivotal role that HER2 plays in tumor growth and its relationship with therapeutic efficacy in gastric carcinomas, and because EBVaGC was recently proposed as a subtype of gastric carcinoma [24], we wanted to examine the expression of HER2 in EBVaGC. Here, ERBB2 is linked to gastric carcinoma.